Cannabics Pharmaceuticals Stock Technical Analysis

CNBX Stock  USD 0.01  0  17.00%   
As of the 16th of April 2024, Cannabics Pharmaceuticals shows the Downside Deviation of 47.37, mean deviation of 16.44, and Risk Adjusted Performance of 0.0777. Cannabics Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Cannabics Pharmaceuticals, which can be compared to its peers. Please confirm Cannabics Pharmaceuticals coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Cannabics Pharmaceuticals is priced correctly, providing market reflects its regular price of 0.0117 per share. As Cannabics Pharmaceuticals appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Cannabics Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cannabics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Cannabics
  
Cannabics Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Cannabics Pharmaceuticals technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Cannabics Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cannabics Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Cannabics Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cannabics Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Cannabics Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Cannabics Pharmaceuticals. You can use it to identify possible trend reversals for Cannabics Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cannabics Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Cannabics Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Cannabics Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of    , which may suggest that Cannabics Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Cannabics Pharmaceuticals price change compared to its average price change.

About Cannabics Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cannabics Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cannabics Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Cannabics Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Cannabics Pharmaceuticals. By analyzing Cannabics Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cannabics Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cannabics Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.

Cannabics Pharmaceuticals April 16, 2024 Technical Indicators

Most technical analysis of Cannabics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cannabics from various momentum indicators to cycle indicators. When you analyze Cannabics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cannabics Pharmaceuticals. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Cannabics Pharmaceuticals information on this page should be used as a complementary analysis to other Cannabics Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Cannabics OTC Stock analysis

When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Please note, there is a significant difference between Cannabics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cannabics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cannabics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.